Literature DB >> 21937986

The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity.

J E Bakema1, M van Egmond.   

Abstract

Immunoglobulin A (IgA) is commonly recognized as the most prevalent antibody (Ab) at mucosal sites with an important role in defense by shielding mucosal surfaces from invasion by pathogens. However, its potential to both actively dampen excessive immune responses or to initiate potent proinflammatory cellular processes is less well known. Interestingly, either functional outcome is mediated through interaction with the myeloid IgA Fc receptor FcαRI (CD89). Monomeric interaction of IgA with FcαRI triggers inhibitory signals that block activation via other receptors, whereas multimeric FcαRI crosslinking induces phagocytosis, reactive oxygen species production, antigen presentation, Ab-dependent cellular cytotoxicity, and cytokine release. Thus, FcαRI acts as a regulator between anti- and proinflammatory responses of IgA. As such, the biology of FcαRI, and its multifaceted role in immunity will be the focus of this review.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21937986     DOI: 10.1038/mi.2011.36

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  60 in total

1.  IgA attenuates anaphylaxis and subsequent immune responses in mice: possible application of IgA to vaccines.

Authors:  Kouya Yamaki; Takayuki Nakashima; Kenji Miyatake; Yuki Ishibashi; Ayaka Ito; Ayu Kuranishi; Akihito Taguchi; Ayumi Morioka; Midori Yamamoto; Shin Yoshino
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

Review 2.  IgA nephropathy: clearance kinetics of IgA-containing immune complexes.

Authors:  Ann Chen; Sung-Sen Yang; Tsai-Jung Lin; Shuk-Man Ka
Journal:  Semin Immunopathol       Date:  2018-09-14       Impact factor: 9.623

3.  Long-lived plasma cells are generated in mucosal immune responses and contribute to the bone marrow plasma cell pool in mice.

Authors:  A Lemke; M Kraft; K Roth; R Riedel; D Lammerding; A E Hauser
Journal:  Mucosal Immunol       Date:  2015-05-06       Impact factor: 7.313

Review 4.  Considerations for the Design of Antibody-Based Therapeutics.

Authors:  Dennis R Goulet; William M Atkins
Journal:  J Pharm Sci       Date:  2019-06-04       Impact factor: 3.534

Review 5.  New concepts in the generation and functions of IgA.

Authors:  Oliver Pabst
Journal:  Nat Rev Immunol       Date:  2012-10-29       Impact factor: 53.106

Review 6.  IgA Responses to Microbiota.

Authors:  Jeffrey J Bunker; Albert Bendelac
Journal:  Immunity       Date:  2018-08-21       Impact factor: 31.745

Review 7.  Control of lung defence by mucins and macrophages: ancient defence mechanisms with modern functions.

Authors:  William J Janssen; Adrianne L Stefanski; Bruce S Bochner; Christopher M Evans
Journal:  Eur Respir J       Date:  2016-09-01       Impact factor: 16.671

Review 8.  Evolution of B cell immunity.

Authors:  David Parra; Fumio Takizawa; J Oriol Sunyer
Journal:  Annu Rev Anim Biosci       Date:  2013-01       Impact factor: 8.923

Review 9.  Re-thinking the functions of IgA(+) plasma cells.

Authors:  Jennifer L Gommerman; Olga L Rojas; Jörg H Fritz
Journal:  Gut Microbes       Date:  2014

10.  Fc receptor-mediated immune responses: new tools but increased complexity in HIV prevention.

Authors:  Diego A Vargas-Inchaustegui; Marjorie Robert-Guroff
Journal:  Curr HIV Res       Date:  2013-07       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.